Last Price | 199.92 | Max Price | 199.92 |
Min Price | 199.92 | 1 Year return | 81.75 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 1 | 2,019,579 | 0.00 % |
2020 | 1 | 2,170,517 | 0.00 % |
2021 | 3 | 2,404,876 | 0.00 % |
2022 | 7 | 2,645,792 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
The core activities of Ignyta Inc. are in the health care eq. & services sector. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
The stock lost over the past 12 months at around 58 percent. Over the period 2011-2016 the stock rose a massive 24,06 percent.
Ignyta Inc. didn't pay out any dividends (in the past 5 years).
As per the end of 2015 the American company's balance sheet equaled 196,15 million dollars. The total debt was around 60,16 million dollars. This is 30,67 percent of the total balance sheet. As per the end of 2015 Ignyta Inc.'s price/earnings-ratio equaled -2. So investors paid for 1 stock -2 times the earnings per share of 2015. Based on the classical stock valuation theories the American stock can be seen as a value stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 346,15 million dollars. At the end of 2015 the American company had around 26,85 million stocks listed.
All Ignyta Inc.'s annual reports can be found here. More information about Ignyta Inc. can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
1
|
1
|
Costs |
0
|
0
|
0
|
7
|
31
|
38
|
Profit |
0
|
0
|
0
|
-7
|
-30
|
-37
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
-2653.57
|
-3019.51
|
ROI |
0.0
|
0.0
|
0.0
|
-68.97
|
-439.00
|
-130.41
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
0
|
10
|
7
|
28
|
Debt |
0
|
0
|
0
|
1
|
44
|
31
|
Total assets |
0
|
0
|
0
|
11
|
50
|
60
|
Solvency |
0.0
|
0.0
|
0.0
|
88.75
|
13.41
|
47.76
|
Cash |
0
|
0
|
0
|
11
|
4
|
54
|
Cashflow |
0
|
0
|
0
|
-6
|
-20
|
-28
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
0.0
|
-4.88
|
-0.46
|
-0.90
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
0.0
|
199.92
|
Eps |
0.0
|
0.0
|
-0.18
|
-0.80
|
-1.00
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
-199.92
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
0.0
|
0.27
|
0.18
|
0.77
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow per stock |
0.0
|
0.0
|
-0.16
|
-0.54
|
-0.75
|
Stocks |
0
|
0
|
37
|
37
|
37
|
Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
7.436.94
|
Date
|
Price
|
---|---|
22 Apr 2025
|
199.92
|
09 Apr 2025
|
199.92
|
08 Apr 2025
|
199.92
|
03 Apr 2025
|
199.92
|
30 Mar 2025
|
199.92
|
27 Mar 2025
|
199.92
|
26 Mar 2025
|
199.92
|
20 Mar 2025
|
199.92
|
15 Mar 2025
|
199.92
|
12 Mar 2025
|
199.92
|
01 Mar 2025
|
199.92
|
25 Feb 2025
|
199.92
|
23 Feb 2025
|
199.92
|
18 Feb 2025
|
199.92
|
13 Feb 2025
|
199.92
|
12 Feb 2025
|
199.92
|
07 Feb 2025
|
199.92
|
02 Feb 2025
|
199.92
|
21 Jan 2025
|
199.92
|
17 Jan 2025
|
199.92
|
09 Jan 2025
|
199.92
|
17 Dec 2024
|
199.92
|
10 Dec 2024
|
199.92
|
06 Dec 2024
|
199.92
|
03 Dec 2024
|
199.92
|
29 Nov 2024
|
199.92
|
27 Nov 2024
|
199.92
|
13 Nov 2024
|
199.92
|
08 Nov 2024
|
199.92
|
05 Nov 2024
|
199.92
|